Alphamab Oncology Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-113.94	166.34	-210.59	-325.72	-412.42
Depreciation & Amortization	64.68	77.03	69.12	55.19	41.1
Loss (Gain) From Sale of Assets	0.68	0.25	0.1	0.01	-
Stock-Based Compensation	18.48	2.53	5.72	13.29	8.17
Other Operating Activities	-23.51	-46.93	-75.19	-82.62	5.17
Change in Accounts Receivable	-49.93	-9.39	8.36	-7.88	-7.61
Change in Inventory	-26.08	-3.06	-14.11	-6.73	-13.59
Change in Accounts Payable	55.56	8.56	1.26	31.09	44.71
Change in Unearned Revenue	-13.3	13.86	-3.05	1.93	15.12
Change in Other Net Operating Assets	-34.54	3.15	15.55	21.14	-1.25
Operating Cash Flow	-121.89	212.34	-202.84	-300.31	-320.6
Capital Expenditures	-31.59	-21.77	-36.18	-129.65	-158.12
Sale of Property, Plant & Equipment	0.36	0.22	-	-	-
Investment in Securities	-632.23	-139.34	-39.52	946.14	664.22
Other Investing Activities	34.61	67.97	57.6	34.26	68.16
Investing Cash Flow	-628.85	-92.93	-18.11	850.76	574.26
Long-Term Debt Issued	313.14	127.25	465	401.07	692.47
Total Debt Issued	313.14	127.25	465	401.07	692.47
Long-Term Debt Repaid	-379.12	-207.93	-552.89	-692.95	-313.97
Total Debt Repaid	-379.12	-207.93	-552.89	-692.95	-313.97
Net Debt Issued (Repaid)	-65.99	-80.68	-87.89	-291.88	378.5
Issuance of Common Stock	2.41	0.14	329.43	0.25	0.35
Repurchase of Common Stock	-27.93	-9.19	-	-	-
Other Financing Activities	-6.8	-9.23	-23.46	-19.28	-14.94
Financing Cash Flow	-98.31	-98.96	218.07	-310.9	363.9
Foreign Exchange Rate Adjustments	-4.26	5.69	19.67	26.34	0.42
Net Cash Flow	-853.3	26.13	16.8	265.88	617.99
Free Cash Flow	-153.48	190.56	-239.02	-429.96	-478.72
Free Cash Flow Margin	-27.11%	29.77%	-109.26%	-257.70%	-327.84%
Free Cash Flow Per Share	-0.16	0.19	-0.25	-0.46	-0.51
Cash Interest Paid	6.8	9.23	11.32	19.28	14.94
Levered Free Cash Flow	-106.62	139.12	-186.64	-332.02	-330.88
Unlevered Free Cash Flow	-101.97	145.32	-179.02	-323.14	-322.64
Change in Working Capital	-68.29	13.12	8.01	39.55	37.38

Source: S&P Global Market Intelligence. Standard template. Financial Sources.